文献速递肺栓塞与肺血管病

6-巯基嘌呤激活Nur77通过BMP信号预防肺动脉高压进展

Prevention of progression of pulmonary hypertension by the Nur77 agonist 6-mercaptopurine: role of BMP signalling.
PubMed 文献 · Eur Respir J · 2019-09-29

该研究探讨孤儿核受体Nur77在肺动脉高压(PAH)中的作用,发现PAH患者肺组织及培养的肺微血管内皮细胞中Nur77表达降低。6-巯基嘌呤(6-MP)激活Nur77可恢复内皮细胞功能、增加BMP信号并抑制血管重塑,在Sugen/缺氧大鼠模型中预防并逆转严重血管增殖性PAH及右心室肥厚。

要点

  • PAH患者肺组织及肺微血管内皮细胞中Nur77表达降低
  • 6-MP激活Nur77可恢复内皮细胞功能并增加BMP信号
  • 6-MP在Sugen/缺氧大鼠模型中预防并逆转血管重塑和右心室肥厚

核心结论

  • Nur77通过抑制血管重塑和增加BMP信号在PAH中起关键调节作用,激活Nur77可能是PAH有前景的治疗选择。

研究设计与样本

  • 研究采用培养的肺微血管内皮细胞(MVECs)、PAH患者肺组织及Sugen/缺氧大鼠模型。

主要发现

  • Nur77在培养的肺微血管内皮细胞和PAH患者肺组织中表达降低。
  • Nur77显著增加MVECs的BMP信号并强烈抑制增殖和炎症。
  • 过表达Nur77的PAH MVECs条件培养基抑制健康平滑肌细胞生长。
  • 6-MP药理性激活Nur77通过正常化增殖、炎症和BMP信号显著恢复MVEC功能。
  • 6-MP在Sugen/缺氧大鼠模型中预防并逆转严重血管增殖性PAH的异常血管重塑和右心室肥厚。

临床怎么用

  • 6-MP激活Nur77可能作为PAH治疗策略,但需进一步临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pulmonary arterial hypertension (PAH) is a progressive fatal disease characterised by abnormal remodelling of pulmonary vessels, leading to increased vascular resistance and right ventricle failure. This abnormal vascular remodelling is associated with endothelial cell dysfunction, increased proliferation of smooth muscle cells, inflammation and impaired bone morphogenetic protein (BMP) signalling. Orphan nuclear receptor Nur77 is a key regulator of proliferation and inflammation in vascular cells, but its role in impaired BMP signalling and vascular remodelling in PAH is unknown.We hypothesised that activation of Nur77 by 6-mercaptopurine (6-MP) would improve PAH by inhibiting endothelial cell dysfunction and vascular remodelling.Nur77 expression is decreased in cultured pulmonary microvascular endothelial cells (MVECs) and lungs of PAH patients. Nur77 significantly increased BMP signalling and strongly decreased proliferation and inflammation in MVECs. In addition, conditioned medium from PAH MVECs overexpressing Nur77 inhibited the growth of healthy smooth muscle cells. Pharmacological activation of Nur77 by 6-MP markedly restored MVEC function by normalising proliferation, inflammation and BMP signalling. Finally, 6-MP prevented and reversed abnormal vascular remodelling and right ventricle hypertrophy in the Sugen/hypoxia rat model of severe angioproliferative PAH.Our data demonstrate that Nur77 is a critical modulator in PAH by inhibiting vascular remodelling and increasing BMP signalling, and activation of Nur77 could be a promising option for the treatment of PAH.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Kurakula K, Sun XQ, Happé C, et al. Prevention of progression of pulmonary hypertension by the Nur77 agonist 6-mercaptopurine: role of BMP signalling. Eur Respir J. 2019. PMID: 31273046. doi:10.1183/13993003.02400-2018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。